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Abstract 
  A spectrophotometric method is developed for the determination of some drugs containing amino groups 
(sulfacetamide sodium, lidocaine and terbutaline sulfate) based on their reaction with p-chloranilic acid reagent in an 
organic medium forming colored charge transfer complexes. The complexes have maximum absorptions at 530 and 527 
nm for sulfacetamide sodium and lidocaine respectively, but terbutaline sulfate gave two maximum absorptions at 529 and 
319 nm. Beers law is obeyed over the concentration range of 10-60 µg.ml
-1
 for sulfacetamide sodium and lidocaine and 5-
70 µg.ml
-1
 for terbutaline sulfate. The molar absorptivity values are 0.940×10
3
, 0.913×10
3
 L.mol
-1
.cm
-1
 for sulfacetamide 
sodium and lidocaine respectively while terbutaline sulfate gave 0.987×10
3
 L.mol
-1
.cm
-1
 at 529 nm and 7.407×10
3
 L.mol
-
1
.cm
-1
 at 319 nm with accuracy range between 100.20% and 101.42% and RSD better than 3.15% for all drugs. The 
method is applied successfully for determination of these drugs in pharmaceutical formulations and compared favorably 
with British Pharmacopeia standard methods. F and t tests are less than the tabulated values at 95% confidence level. 
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Introduction 
        Sulfa drugs are among the first pharmaceutical agents used in veterinary practice. These drugs are widely used in 
the treatment of infections, especially for patients intolerant to other antibiotics [1,2] Sulfacetamide (I) is active against 
Gram positive bacteria, Gram negative bacteria, Chlamydia and Mode of resistance [3]. 
         Terbutaline sulfate (II) is widely used as a prophylactic drug as well as to prevent acute exacerbations of asthma, 
chronic bronchitis, emphysema and other lung diseases. It relaxes muscles and opens air passage in the lungs, making 
them easier to breathe [4,5]. It is a short-acting bronchorelaxant which can be given orally [6]. It is readily metabolized in 
the gut wall and liver when given orally. It has a short duration of action [7].  
      Lidocaine (III) is a common local anesthetic [8] and antiarrhythmic drug  used to treat burning and pain from skin 
inflammations. Lidocaine patches are used to relieve the pain of post-herpetic neuralgia (the burning, stabbing pains or 
aches that may last for months or years after a shingles infection) [9]. 
       Viscous lidocaine is used to relieve pain and discomfort from a sore throat/mouth. It is also used to numb the lining of 
the mouth and throat before certain medical/dental procedures (e.g., dental impressions) [10]. 
Different analytical techniques have been described for determination of  sulfacetamide sodium, lidocaine and 
terbutaline sulfate, such as HPLC [11-13], voltammetry [14-16], GC [17,18] and Spectrofluorimetry [19]. These methods 
are often time-consuming, expensive, and cumbersome. Spectrophotometry continues to be very popular, because of its 
simplicity, versatility and low cost. Several spectrophotometric methods using different reagents have been reported for 
determination of sulfacetamide sodium, lidocaine and terbutaline sulfate. Diazotization coupling method using 8-
hydroxyquinoline [20], iminodibenzyl [21], Phloroglucinol [22] and 3-Aminophenol [23] as coupling agents for determination 
of  sulfacetamide. 4-Aminoantipyrine in the presence of potassium ferricyanaide [24], Fe (III) in the presence of potassium 
ferricyanide [25] and sodium periodate in the presence of acetylacetone [26] are used for determination of terbutaline 
sulfate. Phenol red or chlorophenol red [27], Bromocresol purple [28] and Sodium nitroprusside in the presence of 
hydroxylamine
 
[29] are used for determination of lidocaine.  
The present method is based on the charge transfer complex formation reaction of above drugs as n-donors with p-
chloranilic acid  as π-acceptor without any derivatization or catalysis. 
  
 
 
 
 
 
Experimental 
Apparatus 
      All spectral absorption measurements are made on a Jenway 6800 U.V- visible double beam and 6305 U.V- visible 
single beam spectrophotometers, with 1-cm matched quartz cuvettes. Heating of solutions is carried out on a water bath 
(SWBD) product by Bio Cote Company. Weighing is carried out on a sensitive balance type of DENVER balance Tp-214 
with four digitals. 
Reagents 
     All chemicals used are of analytical or pharmaceutical grade. 
      p-Chloranilic acid (p-CA) reagent  (Fluka)(1×10
-3
M) Solution: It is prepared by dissolving  0.0209 g of  2,5-dichloro-
3,6-dihydroxy-1,4-p-benzoquinone (p-CA) in absolute ethanol (99.9%) in 100 ml volumetric flask. The solution is prepared 
daily and used immediately. 
Standard solutions of pure forms drugs (250µg.ml
-1
)(SDI, Sammara-Iraq) 
A 0.025g of sulfacetamide sodium and lidocaine are dissolved separately in ethanol and terbutaline sulfate 
dissolved in 10ml methanol. The volumes were completed to 100ml with absolute ethanol. These solutions are prepared 
daily and used immediately. 
Sulfacetamide sodium eye drops (100 mg/ml)/ (Amman pharmaceutical industries, Jordan)  
A volume of 0.5 ml of 100 mg.ml
-1
 sulfacetamide is diluted by absolute ethanol to 50 ml in a volumetric flask and 
filtrated through Whattman filter paper no.4 containing anhydrous sodium sulfate to remove the water content, then 12.5ml 
portion from the filtrate is diluted to 50ml by absolute ethanol, and this gave a solution containing 250 µg.ml
-1
 
sulfacetamide sodium. 
                   I 
Sulfacetamide sodium 
M.Wt=254.24 g.mol-1 
                 II 
Terbutaline sulfate  
M.Wt= 548.7 g.mol-1 
                 III 
Lidocaine  
M.Wt= 548.7 g.mol-1 
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Lidocaine gel (2% w/w)/ (Sina-Darou Tehran-Iran)  
An amount equivalent to 5.0 g of lidocaine hydrochloride gel is weighed accurately and dissolved in 5ml of 36 % 
hydrochloric acid and heated in water bath for 10min to increase the solubility, then allowed to cool and transferred to a 
250 ml separating funnel. 20 ml distilled water was added followed by addition of 5M sodium hydroxide until the solution 
became alkaline
 [12]
, then extraction with three portions of 10ml chloroform is performed. The chloroform extracts filtered 
through 2g anhydrous sodium sulphate and the filtrate is completed to 100ml by absolute ethanol; a solution containing 
1000µg.ml-1 lidocaine has been obtained. From this solution 12.5ml was taken and diluted to 50ml by absolute ethanol, 
the final concentration was 250μg.ml
-1
lidocaine. 
Terbutaline sulfate tablets (5mg)/ (Mediotic Labs, Homs – Syria)   
An accurately weighed portion of the powder equivalent to 0.025g terbutaline sulfate is dissolved in 20 ml 
methanol, heating with stirrer to increase the solubility, filtered into 50ml volumetric flask completed to the volume with 
absolute ethanol (the solution was equivalent to 500 μg.ml
-1
 terbutaline sulfate). From this solution a 250μg.ml
-1
 terbutaline 
sulfate solution was prepared  
General procedure  
An increased volumes of 250μg.ml
-1
 working solutions of sulfacetamide sodium, lidocaine and terbutaline sulfate were 
transferred to a series of 5 ml volumetric flasks to cover the concentration range 10 – 60 μg.ml
-1
  for sulfacetamide sodium 
and lidocaine and 5 – 70  μg.ml
-1
 for terbutaline sulfate solutions, followed by the addition of 1.4, 1.6, and 0.8 ml of 1×10
-
3
M of p-CA respectively, diluted to the mark with absolute ethanol and the absorbance was measured at 530 and 527nm 
for sulfacetamide sodium and lidocaine respectively and terbutaline sulfate was measured at 529 and 319 nm against their 
respective blank after 5 min at room temperature. 
Results and Discussion  
Absorption spectra  
The spectrum of p-CA, as π-acceptor,  in absolute ethanol exhibits an absorption band at 460 nm. The addition 
of  sulfacetamide sodium, lidocaine or terbutaline sulfate, as n-donors, to this solution cause an immediate shift with new 
characteristic bands at 530 nm for sulfacetamide, 527 nm for lidocaine where as terbutaline shows two absorption bands 
at 529 and 319 nm when measured against their respective blank (Fig.1). These bands may be attributed to the formation 
of  p-CA radical anions and the band at 319 nm may be attributed to the interaction of p-CA with the hydroxyl group 
present in terbutaline forming n-π charge transfer complex.  
Fig. 1: Absorption spectra of a) 50 µg.ml
-1
 sulfacetamide sodium versus blank, b) 50 µg.ml
-1
                        
         lidocaine versus blank, c) 60 µg.ml
-1
terbutaline sulfate versus blank and d) reagent                                        
blank versus ethanol. 
Optimization of conditions 
Effect of solvent  
It was observed that p-CA react with water (electron-rich agent) to form charge-transfer complex giving a violet 
colored product according to the following mechanism, scheme (1) [30]: 
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Scheme 1: Reaction of water with p-CA 
        Therefore water was canceled in all the subsequent experiments in this work. Different organic solvents like 
methanol, ethanol, acetone, acetonitrile, propanol and butanol are examined. It was observed that using absolute ethanol, 
as solvent for both p-CA and drugs and also for dilution, gave maximum absorbance intensity at respective λmax. 
Therefore; this solvent was used in all subsequent experiments. 
Effect of temperature and developing time 
The effect of temperature on the rate of reaction between p-CA and drugs is studied by mixing of 1 ml of each 
sulfacetamide sodium, lidocaine and terbutaline sulfate respectively and separately with 1 ml of 1×10
-3
 M p-CA in 5 ml 
volumetric flasks. The results indicate that complexes are formed after addition of reagent immediately at room 
temperature (25
○
C). The complexes remain constant for more than 24 hr. However, 5 minutes as developing time is 
recommended in subsequent experiments.  
 
      Fig.2: Effect of time on the absorbance of drug-p-CA complexes 
Effect of p-CA reagent concentration    
         The effects of changing the volume of 1×10-3 M p-CA is studied over the range of 0.0-2.0 ml in a 
solution containing 50 μg.ml
-1
 sulfacetamide sodium, terbutaline sulfate and lidocaine. The results, as shown in Fig. 3, 
reveal the fact that 1.4, 0.8 and 1.6 ml of p-CA respectively is required to achieve the maximum intensity of the color in 
final dilution with ethanol.   
 
       Fig.3: Effect of p-CA reagent on the absorbance of drug complexes 
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Effect of surfactants 
        The effect of   various surfactants including SDS, CTAB, Tween-80 and Triton x-100, of 0.1% concentration, on the 
absorption intensity of the p-CA-drugs complexes are investigated. Tween-80 has no effect on the absorbance, other 
surfactants have negative effects. 
However; the optimum conditions for the reaction of p-CA with the intended drugs are summarized in Table (1). 
Table (1): Optimum reaction conditions for the determination of drugs 
Compound 
λmax 
(nm) 
Temp. 
p-CA 
1×10
-3
M 
(ml) 
Development 
time 
(min.) 
Stability 
period 
(min.) 
 
Final 
pH 
Sulfacetamide 
sodium 
530 R.T* 1.4 5 60 3.65 
Lidocaine 
 
527 
R.T 1.6 5 60 4.02 
Terbutaline sulfate 
529 
R.T 0.8 5 60 2.68 
319 
           *R.T = Room temperature (25 ºC) 
Quantitation 
In order to investigate the range in which the colored complexes adhere to Beer's law, the absorbance of the 
complexes were measured at their corresponding λmax value after developing the color by following the general procedure 
for individual calibrations for a series of solutions containing increasing amounts of each drug (Figure 4). The Beer's law 
limits, molar absorptivity and Sandell's sensitivity values were evaluated and given in Table 2. The linearity was 
represented by the regression equation and the corresponding correlation coefficient for the studied determined drugs by 
the proposed method represents excellent linearity. The relative standard deviation (RSD) and accuracy (average 
recovery %) for the analysis of four replicates of each three different concentrations for each drug indicated that the 
method is precise and accurate. Limit of detection (LOD) and limit of quantitation (LOQ) are in the accepted range below 
the lower limit of Beer's law range (Table 3).  
 
 
 
 
 
 
 
 
 
                      
 
 
 
                           
                         Fig. (4): Calibration graphs for determination of drugs  
Table (2) Characteristics parameters for complexes of the studied drugs 
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Parameter 
Sulfacetamide 
sodium 
Lidocaine 
Terbutaline 
sulfate at 529 
nm 
Terbutaline 
sulfate at 319 
nm 
Linearity range 
(µg.ml
-1
) 
10 – 60 10 - 60 5 - 70 5 - 70 
Molar absorptivity 
(L.mol
-1
.cm
-1
) 
940.7 913.8 987.7 7407.5 
Sandell's Sensitivity 
(µg.cm
-2
) 
0.27 0.25 0.55 0.07 
LOD 
(µg.ml
-1
) 
0.97 1.35 1.89 1.03 
LOQ 
(µg.ml
-1
) 
2.96 4.11 5.73 3.14 
Average recovery* 
(%) 
101.25 101.42 100.34 100.20 
RSD* ≤3.11 ≤3.44 ≤3.51 ≤0.69 
Slope 0.0037 0.0039 0,0018 0.0135 
Intercept 0.0042 0.0004 0.0005 0.0101 
Correlation 
coefficient 
0.9989 0.9982 0.9985 0.9992 
             * Average of four determinations. 
Selectivity 
In order to evaluate the selectivity of the proposed method for the analysis of pharmaceutical formulations, the 
effect of the presence of common excipients was tested for possible interference in the assay by placebo and synthetic 
mixture analyses. 
Three different placebo contents, as described in Table 3, were prepared by mixing amounts of pure sulfacetamide 
sodium, terbutaline sulfate and lidocaine separately with different amounts of starch, acacia, lactose, methylpraben (MHB) 
and ethylparben (BHB). Mixed together and dissolved in 30 ml absolute ethanol (except for terbutaline sulfate dissolved in 
20 ml methanol). The contents are shaken well for 20 min and filtered through filter paper and the filtrate is completed to 
50 ml ethanol absolute in a volumetric flask. An amount equivalent to 50 µg.ml
-1
 of each drug is measured under the 
optimum conditions by following the recommended procedure.  
The analysis of synthetic mixture solution prepared as described earlier yielded percent recoveries which ranged between 
95.34 and 101.58 for three different placebo (Table 4). The results of this study showed that the inactive ingredients did 
not interfere in the assay indicating the high selectivity of the proposed method.  
      
Table (3): Placebo contents of exciepients 
 
Placebo no. 
Content (mg) 
starch acacia lactose methylpraben ethylparben 
1 10 15 10 10 10 
2 15 20 15 15 20 
3 5 10 5 20 15 
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Table (4): Effect of exciepients on the determination of 50µg.ml
-1
of drugs. 
No. of placebo 
Recovery% 
Sulfacetamide 
sodium 
Terbutaline sulfate 
Lidocaine 
at 529nm At 319nm 
1 101.5791 98.6111 99.2908 96.1966 
2 99.1872 100.2541 100.8511 95.3419 
3 100.1953 100.4717 95.3192 96.1966 
 
Composition and stability constant (Kst) of the complexes 
 The compositions of all charge transfer complexes are found to be 1:1 by both Job’s and mole ratio methods. The 
results are shown in the Figures (5).  
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Fig. 5: Continuous variation and mole ratio plots of drug–p-CA complexes 
The average stability constant (Kst) in (L.Mol
-1
) for three different concentrations of each drug is 4.3×10
6 
for sulfacetamide 
sodium, 3.2×10
6 
for lidocaine, 2.1×10
6
 for terbutaline sulfate at 529 nm and 4.8×10
5
 for terbutaline sulfate at 319 nm 
indicating the high stability of complexes. 
Reaction mechanism 
   The interaction of the studied drugs with p-CA in organic solvent, was a charge-transfer complexation reaction 
between the present amino group in the drugs as n-donor and p-CA as π-acceptor, followed by the formation of a radical 
anion. Complete electron transfer from the donor to the acceptor moiety took place with the formation of intensely 
colored radical ions (scheme 2)  
[Terbutaline sulfate]/[Terbutaline 
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[Lidocaine]/[Lidocaine]+[p-CA] 
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[Lidocaine]/[p-CA] 
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Scheme 2: Proposed mechanisms of charge transfer complex formation reaction for assay of the drugs by p-CA. 
 
Application of the developed method on the pharmaceutical formulations 
The proposed method was applied for estimation of the studied drugs in pharmaceutical formulations, three 
concentrations for each drug was used. The obtained average recovery% ranges between 95.05 and 97.99 indicates that 
the method is accurate and the RSD% is ≤ 4.75 indicate the method is precise, (Table 5). The method was compared with 
the British Pharmacopeia [31] procedures, which are depended upon the  potentiometric titration. The obtained results 
were compared statistically by a Student's t-test for accuracy and a variance ratio F-test for precision at the 95% 
confidence level with six degrees of freedom, as cited in Table 5. The results showed that the experimental t-test and F-
test were less than the theoretical value ( t=2.45, F=6.39 ), indicating that there was no significant difference between the 
proposed method and official method. 
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Table (5): Results of Assay of Assay of drug in pharmaceutical preparations using the proposed method. 
Pharmaceutical 
preparation 
Certified 
Value 
Amount 
present 
(µg.ml
-1
) 
Drug content 
found
* 
Recovery
* 
(%) 
Average 
recovery 
(%) 
RSD% 
Sulfacetamide 
sodium eye drop 
100mg.ml
-1 
10 9.270 92.703 
95.25 
1.49 
30 28.392 94.64 0.88 
50 49.200 98.405 0.52 
Terbutaline sulfate 
tablet 
(at 529 nm) 
5mg 
20 20.556 102.778 
96.22 
4.75 
40 37.5 93.75 2.73 
60 55.278 92.13 1.84 
Terbutaline sulfate 
tablet 
(at 319 nm) 
5mg 
20 20.03 100.13 
95.05 
0.19 
40 36.026 90.065 0.27 
60 56.97 94.951 0.32 
Lidocaine gel 2% 
10 9.4 93.974 
97.99 
4.14 
30 30.17 100.556 1.28 
50 49.72 99.436 1.82 
*
 Average of four determinations 
         
Table (6): Comparison of the proposed method with official method: 
Drug determined 
Pharmaceutical 
formulation 
Recovery)%( 
*
   
texp. Fexp. Present 
method 
Standard 
method
 
Sulfacetamide sodium 
Apisulfa-10 Sterile 
Eye Drops 
95.249 99.44 1.806 1.677 
Terbutaline sulfate 
at 529nm 
Asmanol tablets 96.219 99.5 0.81 4.476 
Terbutaline sulfate at 
319nm 
Asmanol tablets 95.049 99.5 1.6 4.07 
Lidocaine xylogel 97.986 94.3 1.67 2.57 
   *
 Average for six determinations 
 
Conclusion 
        The proposed spectrophotometric method has been developed for the determination of microgram amounts of 10-
60 μg.ml
-1
 for each of sulfacetamide sodium and lidocaine and 5-70 μg.ml
-1
 for terbutaline sulfate with a good accuracy 
and precision. The statistical analyses show that the data from the proposed method are in a good agreement with those 
of the official method. The method does not require stringent conditions nor any specific reagent or buffer solution and the 
color is stable more than 24 hours. The proposed method has been applied successfully for the assay of the 
pharmaceutical formulations of sulfacetamide sodium  
(eye drops), terbutaline sulfate (tablets) and lidocaine (gel). 
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